4//SEC Filing
LOUGHEED JAMES 4
Accession 0001288469-23-000050
CIK 0001288469other
Filed
Feb 6, 7:00 PM ET
Accepted
Feb 7, 9:46 PM ET
Size
21.2 KB
Accession
0001288469-23-000050
Insider Transaction Report
Form 4
LOUGHEED JAMES
See remarks
Transactions
- Sale
Common Stock
2023-02-03$41.16/sh−45,573$1,875,871→ 6,691 total - Sale
Common Stock
2023-02-03$41.88/sh−2,770$115,994→ 3,921 total - Sale
Common Stock
2023-02-03$40.42/sh−67,601$2,732,108→ 52,264 total - Award
Common Stock
2023-02-03+7,517→ 11,438 total - Award
Common Stock
2023-02-03+23,136→ 34,574 total - Award
Common Stock
2023-02-03+15,423→ 49,997 total - Award
Common Stock
2023-02-03+4,693→ 54,690 total - Award
Common Stock
2023-02-03+3,128→ 57,818 total - Award
Common Stock
2023-02-03+1,456→ 59,274 total - Award
Common Stock
2023-02-03+973→ 60,247 total
Footnotes (7)
- [F1]Represents the weighted average share price of an aggregate total of 67,601 shares sold in the price range of $39.84 to $40.84 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F2]Represents the weighted average share price of an aggregate total of 45,573 shares sold in the price range of $40.845 to $41.84 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F3]Represents the weighted average share price of an aggregate total of 2,770 shares sold in the price range of $41.85 to $41.915 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F4]Represents shares of Common Stock issued to the Reporting Person for the 2022 performance period under the Company's Executive Incentive Bonus Plan (the "Bonus Plan"). All shares were issued pursuant to the Company's 2010 Equity Incentive Plan. Grant amounts were determined based on the award amount earned under the Bonus Plan and the closing price of the Company's Common Stock in trading on The Nasdaq Global Select Market on February 3, 2023. The Reporting Person has deferred settlement of the shares pursuant to a Restricted Stock Unit Election Form entered into by the Reporting Person on December 31, 2021 until the earliest of (i) the date of termination of the executive officer's service to the Company; or (ii) a qualifying change in control.
- [F5]Represents shares of Common Stock issued to the Reporting Person in connection with the achievement of financial performance conditions for the 2022 fiscal year that were approved as part of the 2020 performance-based restricted stock award granted on March 31, 2020. All shares were issued pursuant to the Company's 2010 Equity Incentive Plan. The Reporting Person has deferred settlement of the shares pursuant to a Restricted Stock Unit Election Form entered into by the Reporting Person on December 31, 2021 until the earliest of (i) the date of termination of the executive officer's service to the Company; or (ii) a qualifying change in control.
- [F6]Represents shares of Common Stock issued to the Reporting Person in connection with the achievement of financial performance conditions for the 2022 fiscal year that were approved as part of the 2021 performance-based restricted stock award granted on May 20, 2021. All shares were issued pursuant to the Company's 2010 Equity Incentive Plan. The Reporting Person has deferred settlement of the shares pursuant to a Restricted Stock Unit Election Form entered into by the Reporting Person on December 31, 2021 until the earliest of (i) the date of termination of the executive officer's service to the Company; or (ii) a qualifying change in control.
- [F7]Represents shares of Common Stock issued to the Reporting Person in connection with the achievement of financial performance conditions for the 2022 fiscal year that were approved as part of the 2022 performance-based restricted stock award granted on January 3, 2022. All shares were issued pursuant to the Company's 2010 Equity Incentive Plan. The Reporting Person has deferred settlement of the shares pursuant to a Restricted Stock Unit Election Form entered into by the Reporting Person on December 31, 2021 until the earliest of (i) the date of termination of the executive officer's service to the Company; or (ii) a qualifying change in control.
Documents
Issuer
MAXLINEAR, INC
CIK 0001288469
Entity typeother
Related Parties
1- filerCIK 0001642366
Filing Metadata
- Form type
- 4
- Filed
- Feb 6, 7:00 PM ET
- Accepted
- Feb 7, 9:46 PM ET
- Size
- 21.2 KB